Monthly Communication Report

Organization:	Amyotrophic Lateral Sclerosis Society of Canada/Société Canadienne de la Sclérose Latérale Amyotrophique
Associated registration:	895134-16791-34
Communication date:	2025-02-06
Posted date:	2025-03-06

Designated Public Office Holders who participated in the communication:	Supriya Sharma, Chief Medical Advisor, HC / Senior Medical Advisor for HPFB Health Canada (HC) Melissa Hunt, A/Director General of the Pharmaceutical Drugs Directorate Health Canada (HC) Sophie Sommerer, Director General of the Biologic and Radiopharmaceutical Drugs Directorate Health Canada (HC) Kelly Robinson, Director General of the Marketed Health Products Directorate Health Canada (HC) Sven Schirmer, Senior Advisor from the Assistant Deputy Minister’s Office in the Health Products and Food Branch Health Canada (HC)
List of Details Subject matter Detail Health, Research and Development, Science and Technology Policies or programs related to access to care and potential treatments for the ALS Community.
Responsible Officer who filed this communication report:	Tammy Moore
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.